Coherus BioSciences, Inc. (CHRS) Weighted Average Number of Shares Outstanding, Diluted 2015 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Coherus BioSciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2015 to 2024.
  • Coherus BioSciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 126 M shares, a 58.4% increase year-over-year.
  • Coherus BioSciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 94.2 M shares, a 21.3% increase from 2022.
  • Coherus BioSciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 77.6 M shares, a 2.89% increase from 2021.
  • Coherus BioSciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 75.4 M shares, a 9.63% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 126 M +46.3 M +58.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 94.2 M +16.5 M +21.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 97.7 M +20 M +25.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 87.3 M +9.71 M +12.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 79.3 M +2.02 M +2.61% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 77.6 M +2.18 M +2.89% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 77.7 M -1.27 M -1.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 77.6 M +2 M +2.64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 77.3 M +4.42 M +6.07% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 75.4 M -8.04 M -9.63% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 79 M -8.46 M -9.67% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 75.6 M -13.1 M -14.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 72.8 M -1.58 M -2.13% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 83.5 M +10.3 M +14.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 87.5 M +8.94 M +11.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 88.7 M +15.7 M +21.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 74.4 M +5.28 M +7.63% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 73.2 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 78.5 M +10.7 M +15.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 73 M +9 M +14.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 69.1 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q3 2018 67.8 M +13.8 M +25.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 64 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q3 2017 54.1 M +2.49 M +4.83% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-06
Q3 2016 51.6 M +13.2 M +34.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q3 2015 38.4 M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.